Cost-Utility Analysis of Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke
- 1 January 2001
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 19 (9) , 927-936
- https://doi.org/10.2165/00019053-200119090-00004
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Treating Acute Stroke Patients With Intravenous tPAStroke, 2000
- Time Course of ADC W Changes in Ischemic StrokeStroke, 1999
- Early Intravenous Thrombolysis for Acute Ischemic Stroke in a Community-Based ApproachStroke, 1998
- Intravenous Tissue Plasminogen Activator for Acute Ischemic StrokeStroke, 1998
- An Introduction to Markov Modelling for Economic EvaluationPharmacoEconomics, 1998
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)JAMA, 1995
- Patient preferences for stroke outcomes.Stroke, 1994
- Cost of acute stroke care in Toronto, Canada.Stroke, 1994
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988